Related references
Note: Only part of the references are listed.Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities
Xiao Bao Shen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery and In Vivo Anti-inflammatory Activity Evaluation of a Novel Non-peptidyl Non-covalent Cathepsin C Inhibitor
Xing Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery and SARs of 5-Chloro-N4-phenyl-N2-(pyridin-2-yl)pyrimidine-2,4-diamine Derivatives as Oral Available and Dual CDK 6 and 9 Inhibitors with Potent Antitumor Activity
Yang Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?
Brice Korkmaz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C
Brice Korkmaz et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation
Salome R. T. Rehm et al.
SCIENTIFIC REPORTS (2019)
Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin
Daniel S. John et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Therapeutic targeting of cathepsin C: from pathophysiology to treatment
Brice Korkmaz et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)
Bruce E. Miller et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
The regulatory role of Dipeptidyl peptidase I on the activation of immune granulocytes
Yi Chu et al.
CELL BIOLOGY INTERNATIONAL (2017)
The Role of Neutrophil Elastase Inhibitors in Lung Diseases
Eva Polverino et al.
CHEST (2017)
Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases
Carla Guarino et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)
Kevin Doyle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Aortic Binding of AZD5248: Mechanistic Insight and Reactivity Assays To Support Lead Optimzation
Ryan A. Bragg et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Cathepsin C Inhibitors: Property Optimization and Identification of a Clinical Candidate
Mark Furber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
E-64c-Hydrazide: A Lead Structure for the Development of Irreversible CathepsinC Inhibitors
Hanna Radzey et al.
CHEMMEDCHEM (2013)
Neutrophil recruitment and function in health and inflammation
Elzbieta Kolaczkowska et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Neutrophil Serine Proteases Promote IL-1β Generation and Injury in Necrotizing Crescentic Glomerulonephritis
Adrian Schreiber et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2
Anne Molgaard et al.
BIOCHEMICAL JOURNAL (2007)
Neutrophil serine proteases: specific regulators of inflammation
Christine T. N. Pham
NATURE REVIEWS IMMUNOLOGY (2006)
Mast cell dipeptidyl peptidase I mediates survival from sepsis
JMS Clair et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Chronic obstructive pulmonary disease: molecular and cellular mechanisms
PJ Barnes et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases
D Turk et al.
EMBO JOURNAL (2001)
Share Paper
